Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange

by asepadmin | May 31, 2023 | Uncategorized

Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange VANCOUVER, BC, May 30, 2023 (CNW) — Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that it has engaged Aegis...

Asep Inc. Appoints General Wesley Clark (Ret.), David Johnson, J. Bernard Rice, Dr. Islam Mohamed and Thomas O’Shaughnessy to its Advisory Board and Dr. Rob Stenstrom, as Medical Director

by asepadmin | Mar 6, 2023 | Uncategorized

Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the SepsetER Sepsis Diagnostic Test in China

by asepadmin | Jan 27, 2023 | Uncategorized

Asep Medical Holdings Inc. Announces Adoption of Long-term Performance Incentive Plan, Grant of Stock Options

by asepadmin | Jan 20, 2023 | Uncategorized

Asep Medical Holdings Inc. to Hold Important Investor Information Webinar on January 24, 2023

by asepadmin | Jan 18, 2023 | Uncategorized

Asep Inc. Signs Letter of Intent for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa

by asepadmin | Jan 6, 2023 | Uncategorized